Showing 1 - 20 results of 23 for search 'Zhongxia Wang', query time: 0.07s
Refine Results
-
1
Novel Molecular Targets in Malignant Diseases of Digestive System 2014 by Chunping Jiang, Youmin Wu, Xiao Xu, Zhongxia Wang
Published 2015-01-01
Article -
2
PP2A-Mediated Anticancer Therapy by Weibo Chen, Zhongxia Wang, Chunping Jiang, Yitao Ding
Published 2013-01-01
Article -
3
Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma by Weiwei Shi, Weiwei Shi, Shan Zhang, Shan Zhang, Ding Ma, Ding Ma, Dongliang Yan, Guang Zhang, Guang Zhang, Guang Zhang, Yin Cao, Yin Cao, Yin Cao, Zhongxia Wang, Zhongxia Wang, Zhongxia Wang, Junhua Wu, Chunping Jiang, Chunping Jiang, Chunping Jiang
Published 2020-06-01
Article -
4
SphK2/S1P Promotes Metastasis of Triple-Negative Breast Cancer Through the PAK1/LIMK1/Cofilin1 Signaling Pathway by Weiwei Shi, Ding Ma, Yin Cao, Lili Hu, Shuwen Liu, Dongliang Yan, Shan Zhang, Guang Zhang, Zhongxia Wang, Zhongxia Wang, Junhua Wu, Chunping Jiang, Chunping Jiang
Published 2021-04-01
Article -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Knowledge, attitude, and practice of patients receiving maintenance hemodialysis regarding hemodialysis and its complications: a single-center, cross-sectional study in Nanjing by Fangfang Xu, Bing Zhuang, Zhongxia Wang, Hao Wu, Xin Hui, Hongyan Peng, Xueqin Bian, Hong Ye
Published 2023-09-01
Article -
13
-
14
-
15
-
16
UBE2S promotes malignant properties via VHL/HIF‐1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma by Junyi Wu, Xiangjie Xu, Shasha Wu, Weiwei Shi, Guang Zhang, Yin Cao, Zhongxia Wang, Junhua Wu, Chunping Jiang
Published 2023-09-01
Article -
17
-
18
-
19
CuET overcomes regorafenib resistance by inhibiting epithelial-mesenchymal transition through suppression of the ERK pathway in hepatocellular carcinoma by Ding Ma, Shuwen Liu, Kua Liu, Qinyu He, Lili Hu, Weiwei Shi, Yin Cao, Guang Zhang, Qilei Xin, Zhongxia Wang, Junhua Wu, Chunping Jiang
Published 2024-09-01
Article -
20
EGFR bypass activation mediates acquired resistance to regorafenib in hepatocellular carcinoma by Lili Hu, Lili Hu, Weiwei Shi, Weiwei Shi, Kua Liu, Ding Ma, Qilei Xin, Zhongxia Wang, Yin Cao, Yin Cao, Guang Zhang, Guang Zhang
Published 2024-11-01
Article